v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - CNY (¥)
¥ in Thousands
Ordinary shares
Class A ordinary shares
Ordinary shares
Class B ordinary shares
Ordinary shares
Additional paid-in capital
Statutory reserves
Accumulated other comprehensive income
Accumulated deficit
Class A ordinary shares
Class B ordinary shares
Total
Beginning balance at Dec. 31, 2022     ¥ 32 ¥ 61,947   ¥ 11,800 ¥ (1,954,126)     ¥ (1,880,347)
Beginning balance (in shares) at Dec. 31, 2022     50,000,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income (Loss)             203,117     203,117
Preferred shares redemption value accretion             (536,059)     (536,059)
Disposal of discontinued operations       17,789           17,789
Share-based compensation       38,583           38,583
Exercise of share options     ¥ 5 16,032           16,037
Exercise of share options (in shares)     6,994,625              
Vesting of restricted shares     ¥ 17 (17)            
Vesting of restricted shares (in shares)     25,000,000              
Foreign currency translation adjustment           3,495       3,495
Ending balance at Dec. 31, 2023     ¥ 54 134,334   15,295 (2,287,068)     (2,137,385)
Ending balance (in shares) at Dec. 31, 2023     81,994,625              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income (Loss)             865,846     865,846
Appropriation to statutory reserves         ¥ 80,975   (80,975)      
Preferred shares redemption value accretion             (429,931)     (429,931)
Share-based compensation       64,017           64,017
Vesting of restricted shares     ¥ 17 313           330
Vesting of restricted shares (in shares)     25,000,000              
Foreign currency translation adjustment           3,326       3,326
Ending balance at Dec. 31, 2024     ¥ 71 198,664 80,975 18,621 (1,932,128)     ¥ (1,633,797)
Ending balance (in shares) at Dec. 31, 2024     106,994,625         106,994,625
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net Income (Loss)             1,307,540     ¥ 1,307,540
Appropriation to statutory reserves         149,058   (149,058)      
Preferred shares redemption value accretion             700,795     700,795
Share-based compensation       74,319           74,319
Exercise of share options     435           435
Exercise of share options (in shares) 361,212                  
Vesting of restricted shares     689           689
Vesting of restricted shares (in shares) 19,614                  
Issuance of class A ordinary shares, net of issuance costs ¥ 9     185,518           185,527
Issuance of Class A ordinary shares, net of issuance costs (in shares) 12,400,000                  
Conversion of convertible redeemable preferred shares to Class A ordinary shares upon IPO ¥ 110     2,719,977           2,720,087
Conversion of convertible redeemable preferred shares to Class A ordinary shares upon IPO (in shares) 151,086,581                  
Re-designation of ordinary shares into Class A and Class B ordinary shares upon IPO ¥ 16 ¥ 55 ¥ (71)              
Re-designation of ordinary shares into Class A and Class B ordinary shares upon IPO (in shares) 24,862,125 82,132,500 (106,994,625)              
Foreign currency translation adjustment           (9,300)       (9,300)
Ending balance at Dec. 31, 2025 ¥ 135 ¥ 55   ¥ 3,179,602 ¥ 230,033 ¥ 9,321 ¥ (72,851)     ¥ 3,346,295
Ending balance (in shares) at Dec. 31, 2025 188,729,532 82,132,500           194,348,706 82,132,500